MMV launches the COVID Box to stimulate new drug research
MMV contributes to the global hunt for new therapies for the SARS-CoV-2 virus with the launch of the COVID Box. The aim is to catalyse the discovery of drugs for COVID-19 disease by providing researchers with an initial set of
Covid-19 : l’OMS clarifie sa position sur la transmission asymptomatique
[vc_row][vc_column][vc_column_text]« Depuis début février, nous disons que les personnes asymptomatiques peuvent transmettre la Covid-19, mais que nous avons besoin de plus de recherches pour établir l’étendue de la transmission asymptomatique », a déclaré Tedros Adhanom Ghebreyesus, Directeur général de l’OMS
New Government Guidelines Makes Accelerating Artificial Intelligence Possible
[vc_row][vc_column][vc_column_text]Prior to COVID-19, government investment in AI had surpassed billions of dollars in research and development. With a premium now placed on speed to develop vaccines and diagnostics for the coronavirus, there is a renewed emphasis on the role of
This global pandemic could transform humanitarianism forever: Here’s how
[vc_row][vc_column][vc_column_text]In humanitarian response, there will be a 'before' and 'after' COVID-19," Ed Schenkenberg van Mierop, executive director of the think tank HERE-Geneva, wrote in late March But as the crisis born of this global pandemic has evolved, some of the promises